青少年、成年与晚发性系统性红斑狼疮的缓解、低疾病活动度与复发
该回顾性队列纳入289例按2019 EULAR/ACR标准分类的SLE患者,按发病年龄分为jSLE(<18岁)、aSLE(18-49岁)和lSLE(≥50岁)。lSLE独立预测缓解(HR 2.8)和LLDAS(HR 2.4),jSLE复发率更高(87.5% vs aSLE 66.7% vs lSLE 24.7%),lSLE死亡率更高且感染为主要死因。
要点
- 晚发性SLE独立预测缓解和LLDAS,预后相对较好。
- 青少年起病SLE复发率高达87.5%,是复发的独立危险因素。
- 晚发性SLE死亡率更高,感染为主要死因。
核心结论
- jSLE与更高的复发率相关,而晚发性SLE独立 associated with achieving remission and LLDAS。
研究设计与样本
- 回顾性队列研究,纳入289例按2019 EULAR/ACR标准分类的SLE患者,分为jSLE(<18岁,96例)、aSLE(18-49岁,96例)和lSLE(≥50岁,97例),90.5%为女性。
主要发现
- jSLE诊断时疾病活动度更高,神经精神表现更常见;aSLE以皮肤黏膜受累和肾炎为主。
- lSLE更常达到缓解和LLDAS,lSLE独立预测缓解(HR 2.8;95% CI 1.9-4.0)和LLDAS(HR 2.4;95% CI 1.7-3.4;P < 0.001)。
- 复发率jSLE为87.5%,aSLE为66.7%,lSLE为24.7%(P < 0.001)。
- 与复发相关的因素包括jSLE(HR 2.1;95% CI 1.5-2.9;P = 0.008)和起病时全身表现(HR 1.6;95% CI 1.2-2.4;P = 0.048)。
- lSLE死亡率更高,感染为主要死因。
关键数值与推荐
- 缓解按DORIS定义,低疾病活动度按LLDAS定义,复发按SELENA-SLEDAI Flare Index定义。
- 排除其他自身免疫病,但允许抗磷脂综合征和干燥综合征。
临床怎么用
- 对jSLE患者应加强监测和复发预防,尤其起病时有全身表现者。
- 对lSLE患者应关注感染风险及死亡风险,尽管其缓解和LLDAS达标率更高。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To evaluate remission, low disease activity and relapse in patients with SLE according to age at disease onset. METHODS: We conducted a retrospective cohort study including patients classified with SLE according to the 2019 EULAR/ACR criteria. Patients were grouped by age at onset as juvenile-onset SLE (jSLE, <18 years), adult-onset SLE (aSLE, 18-49 years) and late-onset SLE (lSLE, ≥50 years). Patients with other autoimmune diseases were excluded, except antiphospholipid syndrome and Sjögren. Clinical data and outcomes were obtained from medical records. Remission was defined according to DORIS, low disease activity according to LLDAS and relapse according to the SELENA-SLEDAI Flare Index. RESULTS: A total of 289 patients were included: 96 with jSLE, 96 with aSLE and 97 with lSLE; 90.5% female. At diagnosis, jSLE patients had higher disease activity. Neuropsychiatric manifestations were more frequent in jSLE, while mucocutaneous involvement and nephritis predominated in aSLE. Remission and LLDAS were achieved more frequently in lSLE; concordantly, lSLE independently predicted remission and LLDAS (HR 2.8; 95% CI 1.9-4.0 and HR 2.4; 95% CI 1.7-3.4; P < 0.001). Relapses were more frequent in jSLE (87.5%) compared with aSLE (66.7%) and lSLE (24.7%; P < 0.001). Factors associated with relapse were jSLE (HR 2.1; 95% CI 1.5-2.9; P = 0.008) and constitutional manifestations at onset (HR 1.6; 95% CI 1.2-2.4; P = 0.048). Mortality was higher in lSLE, with infections as the main cause. CONCLUSION: jSLE was associated with higher relapse rates, whereas late-onset SLE was independently associated with achieving remission and LLDAS.
引用
- Vázquez Hernández AE, Godínez-Lazarini E, Cimé-Aké E, et al. Remission, low disease activity and relapse in patients with juvenile-, adult- and late-onset SLE. Rheumatology (Oxford). 2026. PMID: 42745479. doi:10.1093/rheumatology/keag506
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。